Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.
about
Development of a functional antibody by using a green fluorescent protein frame as the templateAntiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin.Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp.Expression of recombinant antibodies.Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy.Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion.Site-specific conjugation of ScFvs antibodies to nanoparticles by bioorthogonal strain-promoted alkyne-nitrone cycloaddition.A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.Codon modification for the DNA sequence of a single-chain Fv antibody against clenbuterol and expression in Pichia pastoris.What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future
P2860
Q33798870-1F52837A-FF7D-40FD-A928-9EB547BEDE6EQ36136323-01974981-39BE-4663-9BA3-DFAAF3A1A900Q36155674-3F6CF711-70CE-4D7F-A5B6-88C64C71CA86Q37282673-1724C18D-9DCD-48BB-AF7F-E0F64841F540Q38126016-AADC3619-EF20-4E0E-B750-D1ABAD9B8AC2Q38904163-75325C28-6A67-4244-AA9A-32ACDCD653B3Q39011393-EF4BC3C6-EFA6-431C-A42E-B25ACC0A31F4Q39376688-301846C9-F62D-4B64-96DA-89DACBB371BEQ39436507-53412793-D686-4A54-9200-894E81204322Q40612349-5A20DDFE-6A58-449A-A91C-638E2B08909CQ41763928-42F7DF89-8FFC-4CA9-AE2B-2F6F6393015FQ45121031-6B9C6746-4DF7-47CE-9EEB-98721AEB753AQ59128232-20A1E687-E70E-4DC7-AB2A-900D97197B1D
P2860
Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Highly efficient production of ...... targeting breast cancer cells.
@en
Highly efficient production of ...... targeting breast cancer cells.
@nl
type
label
Highly efficient production of ...... targeting breast cancer cells.
@en
Highly efficient production of ...... targeting breast cancer cells.
@nl
prefLabel
Highly efficient production of ...... targeting breast cancer cells.
@en
Highly efficient production of ...... targeting breast cancer cells.
@nl
P2093
P2860
P50
P1476
Highly efficient production of ...... targeting breast cancer cells
@en
P2093
Agnese Salvadè
Alessio Lombardi
Davide Prosperi
Patrizia Galeffi
Silvia Sommaruga
P2860
P2888
P304
P356
10.1007/S00253-011-3306-3
P407
P577
2011-05-03T00:00:00Z